MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CGEN Compugen
- 1.5300
- +0.0100+0.66%
Close Dec 20 16:00 ET
- 1.5800
- +0.0500+3.27%
Post 20:01 ET
136.99MMarket Cap51.00P/E (TTM)
1.5900High1.5000Low323.08KVolume1.5300Open1.5200Pre Close492.90KTurnover0.38%Turnover RatioLossP/E (Static)89.54MShares3.030152wk High2.26P/B129.60MFloat Cap1.350052wk Low--Dividend TTM84.71MShs Float19.9000Historical High--Div YieldTTM5.92%Amplitude0.3400Historical Low1.5250Avg Price1Lot Size
About Compugen Company
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Company Profile
SymbolCGEN
Company NameCompugen
Listing DateAug 11, 2000
Issue Price10.00
Founded1993
CEODr. Anat Cohen-Dayag, PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
AddressAzrieli Center,26 Harokmim Street,Building D
CityHolon
ProvinceTel Aviv
CountryIsrael
Zip Code58858
Phone972-3-765-8585
Websitehttp://www.cgen.com
Company Executives
- Name
- Position
- Salary
- Dr. Anat Cohen-Dayag, PhD
- Director, President and Chief Executive Officer
- 1.46M
- Alberto Sessa
- Chief Financial Officer
- --
- Dr. Eran Ophir
- Chief Scientific Officer
- 540.64K
- Dr. Zurit Levine,PhD
- Senior Vice President, Technology Innovation
- 532.26K
- Dr. Yaron Turpaz, PhD
- Senior Vice President and Senior Advisor, Computational Discovery
- --
- Dr. Pierre Ferre, Pd.D
- Vice President, Preclinical Development
- 570.40K
- Paul J. Sekhri
- Chairman of the Board
- --
- Gilead Halevy
- Independent Director
- --
- Dr. Mathias Hukkelhoven, PhD
- Independent Director
- --
- Sanford S. Zweifach
- Independent Director
- --
- Dr. Kinneret Livnat Savitzky, PhD
- Independent Director
- --
- Eran Perry
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.